Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SR-02 in Type 1 Diabetes (SUGR)
NCT07581197Phase 2Not yet recruiting
- Sponsor
- Seraxis
- Start
- Nov 2026
- Primary completion
- Nov 2028
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of SR-02 in type 1 diabetes mellitus (T1D), sponsored by Seraxis. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
SR-02
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07581197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07581197.